{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:00:27Z","timestamp":1791172827693,"version":"4.1.0"},"reference-count":5,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,10,15]]},"published-print":{"date-parts":[[2026,3]]},"DOI":"10.2967\/jnumed.125.270792","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:16:19Z","timestamp":1767111379000},"page":"345-347","source":"Crossref","is-referenced-by-count":2,"title":["Concepts in Phase 1 Radiopharmaceutical Therapy Trial Designs: Lessons from the SNMMI Dose Optimization in Radiopharmaceutical Therapy Development Workshop"],"prefix":"10.2967","volume":"67","author":[{"given":"Michael J.","family":"Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"2026030205300680000_67.3.345.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"2026030205300680000_67.3.345.2","unstructured":"Maguire W . Oncology therapeutic radiopharmaceuticals: dosage optimization during clinical development. U.S. Food and Drug Administration website. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/oncology-therapeutic-radiopharmaceuticals-dosage-optimization-during-clinical-development. Updated August 18, 2025. Accessed October 28, 2025."},{"key":"2026030205300680000_67.3.345.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262751"},{"key":"2026030205300680000_67.3.345.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.270069"},{"key":"2026030205300680000_67.3.345.5","first-page":"252043","article-title":"Comparison of extrapolation methods for animal-to-human dosimetry of PSMA targeting agents: 177Lu-HTK03170 and 177Lu-PSMA-617 [abstract]","volume":"66","author":"Kurkowska","year":"2025","journal-title":"J Nucl Med."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.270792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:30:15Z","timestamp":1772458215000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.270792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":5,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,2]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.2967\/jnumed.125.270792"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.270792","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}